| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q35591553 | A CFTR potentiator in patients with cystic fibrosis and the G551D mutation |
| Q33515286 | A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients. |
| Q33885159 | Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis |
| Q34184239 | An international randomized multicenter comparison of nasal potential difference techniques |
| Q42272044 | An unexpected effect of TNF-α on F508del-CFTR maturation and function |
| Q38975458 | Analysis of nasal potential in murine cystic fibrosis models |
| Q34132007 | Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial |
| Q33982032 | Basic protocol for transepithelial nasal potential difference measurements |
| Q38200801 | Biosynthesis of cystic fibrosis transmembrane conductance regulator |
| Q40504766 | Body temperature measurement in daily practice |
| Q27001087 | CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy: Report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26-29 March 2014 |
| Q34625525 | Characterization of nasal potential difference in cftr knockout and F508del-CFTR mice |
| Q47849183 | Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes |
| Q47261299 | Cis variants identified in F508del complex alleles modulate CFTR channel rescue by small molecules |
| Q33703455 | Clonal relationship and differentiation among Mycobacterium abscessus isolates as determined using the semiautomated repetitive extragenic palindromic sequence PCR-based DiversiLab system |
| Q37333080 | Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis |
| Q33448455 | Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients |
| Q41287880 | Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators |
| Q30415411 | Determinants of refusal of A/H1N1 pandemic vaccination in a high risk population: a qualitative approach |
| Q39106838 | Diagnosis of Cystic Fibrosis in Screened Populations. |
| Q39106842 | Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation |
| Q24295031 | Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect |
| Q36433196 | Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial |
| Q38214213 | European Cystic Fibrosis Society Standards of Care: Best Practice guidelines |
| Q57913645 | European best practice guidelines for cystic fibrosis neonatal screening |
| Q37887174 | European cystic fibrosis bone mineralisation guidelines |
| Q51657861 | Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the delta F508 mutation. |
| Q48746512 | French law: what about a reasoned reimbursement of serum vitamin D assays? |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q37770323 | Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening |
| Q47863675 | Haemophagocytic syndrome in Plasmodium falciparum malaria |
| Q33280494 | In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study |
| Q38969052 | Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment |
| Q33855072 | Inflammation and CFTR: might neutrophils be the key in cystic fibrosis? |
| Q35274557 | Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients |
| Q35609724 | Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report |
| Q38086212 | Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation |
| Q30384047 | Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy. |
| Q37363443 | Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients |
| Q41703064 | Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST). |
| Q33358344 | Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients |
| Q40631095 | Measurement of temperature and fever in children |
| Q40696787 | Mutations in GAS8, a Gene Encoding a Nexin-Dynein Regulatory Complex Subunit, Cause Primary Ciliary Dyskinesia with Axonemal Disorganization. |
| Q34554979 | Mycobacterium abscessus and children with cystic fibrosis |
| Q35070529 | Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease. |
| Q40838889 | NUTRITIONAL STATUS ASSESSMENT IN PATIENTS WITH CYSTIC FIBROSIS |
| Q34706830 | Nebulized antibiotics in cystic fibrosis |
| Q44200339 | Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation |
| Q43879324 | Pain in children and adults with cystic fibrosis: a comparative study |
| Q34776256 | Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients. |
| Q77643466 | Priming of blood neutrophils in children with cystic fibrosis: correlation between functional and phenotypic expression of opsonin receptors before and after platelet-activating factor priming |
| Q38633253 | Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway |
| Q28377318 | Rapid improvement of intracranial tuberculomas after addition of ofloxacin to first-line antituberculosis treatment |
| Q48549396 | Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis |
| Q39477646 | Sputum itraconazole concentrations in cystic fibrosis patients |
| Q33259242 | The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening |
| Q38896160 | The hsa-miR-125a/hsa-let-7e/hsa-miR-99b cluster is potentially implicated in Cystic Fibrosis pathogenesis |
| Q26775974 | US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis |
| Q26775045 | US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary |
| Q56241318 | Un test de la sueur normal n'exclut pas le diagnostic de mucoviscidose |
| Q37570903 | Update on cystic fibrosis-related bone disease: a special focus on children |
| Q39665032 | Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. |
| Q41484061 | Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis |
| Q54043285 | [Antibiotic therapy in cystic fibrosis. II Antibiotic strategy] |
| Q53919111 | [Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients] |
| Q87567669 | [Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement] |
| Q38949076 | rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice |
Search more.